Impact of anticoagulant treatment strategy during initiation of antiarrhythmic drugs on clinical outcomes in atrial fibrillation patients with low CHA2DS2-VASc scores
Key Points
Key points are not available for this paper at this time.
Impact of anticoagulant treatment strategy during initiation of antiarrhythmic drugs on clinical outcomes in atrial fibrillation patients with low CHA2DS2-VASc scores | Synapse
Also Consider
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: